Pregnancy in Women with Type 2 Diabetes: 12 Years Outcome Data 1990-2002
Overview
Affiliations
Aim: Twelve years' outcome analysis of pregnancies in women with Type 2 diabetes in a multiethnic geographically defined area.
Methods: Information about 182 women delivered between 1990 and 2002 was ascertained from a regional computerized database. The main outcome measures were rates of miscarriage, stillbirth, neonatal/postnatal deaths, congenital malformations, birth weight, mode of delivery, and neonatal unit care as well as maternal morbidities of polyhydramnios, postpartum haemorrhage, pregnancy-induced hypertension/pre-eclampsia.
Results: Among 182 singleton pregnancies, 161 (88%) resulted in a live outcome. There were 16 (8.8%) spontaneous miscarriages, two (1.2%) stillbirths, and three (1.6%) terminations. Congenital malformations occurred in 18 pregnancies (99/1000). There were two early and one late neonatal deaths and two further deaths in the postnatal period. Twenty-eight percent of infants were large for gestational age, with 15 (9.3%) greater than 4 kg. Fifty-three percent were delivered by caesarean section and 68 (37%) required admission to neonatal unit (NNU) care. Hypertension/pre-eclampsia was two times, polyhydramnios three times, and postpartum haemorrhage six times more common than in non-diabetic women.
Conclusions: Women with Type 2 diabetes have a less satisfactory pregnancy outcome compared with the general population. Infants have a two-fold greater risk of stillbirth, a 2.5-fold greater risk of a perinatal mortality, a 3.5-fold greater risk of death within the first month and a six-fold greater risk of death up to 1 year compared with regional/national figures. They have an 11 times greater risk of a congenital malformation. We need to develop better educational and screening strategies if we are to improve.
Boggess K, Valint A, Refuerzo J, Zork N, Battarbee A, Eichelberger K JAMA. 2023; 330(22):2182-2190.
PMID: 38085312 PMC: 10716718. DOI: 10.1001/jama.2023.22949.
Neurodevelopmental Programming of Adiposity: Contributions to Obesity Risk.
Skowronski A, Leibel R, LeDuc C Endocr Rev. 2023; 45(2):253-280.
PMID: 37971140 PMC: 10911958. DOI: 10.1210/endrev/bnad031.
Abolhassani N, Winterfeld U, Kaplan Y, Jaques C, Minder Wyssmann B, Del Giovane C BMJ Open Diabetes Res Care. 2023; 11(1).
PMID: 36720508 PMC: 9890805. DOI: 10.1136/bmjdrc-2022-002919.
Females with Diabetes Mellitus Increased the Incidence of Premenstrual Syndrome.
Huang Y, Chien W, Cheng C, Chang Y, Chung C, Cheng C Life (Basel). 2022; 12(6).
PMID: 35743808 PMC: 9224876. DOI: 10.3390/life12060777.
Suppressive Role of Lactoferrin in Overweight-Related Female Fertility Problems.
Sato B, Kanai S, Sakaguchi D, Yajima K, Matsumoto Y, Morohoshi K Nutrients. 2022; 14(5).
PMID: 35267914 PMC: 8912823. DOI: 10.3390/nu14050938.